Most people on semaglutide lose around 15% of their body weight over about 16 months, with the fastest results coming in the first several months after reaching the full dose. For someone starting at 250 pounds, that translates to roughly 37 pounds. But the pace isn’t steady. Weight comes off slowly at first, accelerates as your dose increases, and gradually tapers off as your body adjusts.
What the First Few Months Look Like
Semaglutide starts at a low dose and increases every four weeks over a 16-week period. You begin at 0.25 mg per week, then move to 0.5 mg, 1 mg, and 1.7 mg before reaching the maintenance dose of 2.4 mg around week 17. This gradual ramp-up exists to reduce nausea and other stomach-related side effects, but it also means weight loss during the first month or two is modest. Many people notice reduced appetite almost immediately, but the scale may only move a few pounds in those early weeks.
The real momentum builds once you reach higher doses. By months three and four, most people are losing weight more noticeably, often a pound or more per week. The largest clinical trial of semaglutide for weight loss, known as STEP 1, found that participants lost an average of 14.9% of their body weight over 68 weeks, compared to just 2.4% in the placebo group. That weight loss isn’t evenly distributed across those 68 weeks. It accelerates through the middle months and then gradually slows.
Why Weight Loss Speeds Up, Then Slows Down
Semaglutide works on two fronts. It activates receptors in the hypothalamus and brainstem, the parts of the brain that regulate hunger and fullness, which makes you feel genuinely less interested in food. It also slows the speed at which your stomach empties, so meals keep you satisfied for longer. Together, these effects can significantly cut your daily calorie intake without requiring the kind of white-knuckle willpower that makes most diets fail.
Early on, when you’re eating considerably less than your body is used to, it taps into stored energy to make up the difference. That’s when pounds come off fastest. Over time, though, your metabolism adjusts downward to match your lower intake. Your body burns fewer calories at rest because you’re lighter and because it’s compensating for the sustained calorie deficit. The point where your calorie burn roughly equals your calorie intake is when the plateau hits.
Most people on semaglutide reach this plateau around 60 weeks (roughly 14 months). At that point, the drug is still working. It’s still suppressing appetite and keeping you from regaining. But the active weight loss phase has largely run its course. People who are closer to a healthy weight when they start tend to plateau sooner, because the body has less excess energy to give up before it starts resisting further loss.
A Realistic Month-by-Month Timeline
Individual results vary based on starting weight, diet, activity level, and how your body responds to the medication. But here’s a general picture of what to expect:
- Weeks 1 to 4: You’re on the lowest dose (0.25 mg). Appetite may decrease, but weight loss is minimal, often 1 to 3 pounds. Your body is adjusting to the medication.
- Weeks 5 to 16: Doses increase monthly. Weight loss picks up as you move through 0.5 mg, 1 mg, and 1.7 mg. Most people begin losing noticeably during this stretch.
- Weeks 17 to 40: You’ve reached the full 2.4 mg dose. This is typically the period of fastest, most consistent weight loss. Losses of 1 to 2 pounds per week are common.
- Weeks 40 to 60: Weight loss continues but the pace slows. Your body is adapting to a lower weight and reduced calorie intake.
- Beyond 60 weeks: Most people have plateaued. The focus shifts to maintaining what you’ve lost.
Not All the Weight Lost Is Fat
One important detail that often gets overlooked: a significant portion of the weight you lose on semaglutide comes from lean mass, which includes muscle. Data from the STEP 1 trial showed that about 45% of the total weight lost was lean mass rather than fat. In concrete terms, participants who lost an average of 15.3 kg (about 34 pounds) lost roughly 6.9 kg (15 pounds) of lean tissue.
That ratio is higher than what nutrition researchers typically expect. The general rule of thumb for any weight loss method is that about one-quarter of weight lost comes from lean tissue. Semaglutide appears to exceed that, which raises concerns about long-term muscle strength and metabolic health, particularly for older adults. Resistance training and adequate protein intake during treatment can help preserve muscle, and many clinicians now recommend both as standard practice alongside the medication.
What Affects How Fast You Lose
Your starting weight matters. People with a higher BMI tend to lose more total weight and may see faster early results simply because their bodies have more stored energy to draw from. Someone starting at a BMI of 40 will likely lose more pounds in the first six months than someone starting at 30, even if the percentage of body weight lost ends up being similar.
Diet and exercise make a measurable difference on top of the medication’s effects. Semaglutide was studied alongside a reduced-calorie diet and increased physical activity, so the trial results reflect that combination, not the drug alone. People who treat semaglutide as a standalone solution without changing eating or movement habits generally see smaller losses.
Dose tolerance also plays a role. If side effects like nausea or stomach discomfort are significant, your doctor may delay the dose increase by four weeks at any step. That means it could take 20 or more weeks to reach the full dose instead of 17, which can push back the timeline for peak weight loss. This isn’t a setback; it’s a normal part of the process that doesn’t change long-term outcomes.
Keeping the Weight Off
Semaglutide is not a short-term treatment. Studies consistently show that people regain a substantial portion of lost weight after stopping the medication, because the appetite-suppressing effects disappear once the drug clears your system. For most people, maintaining results means staying on the medication long term or transitioning to a comprehensive plan that includes dietary changes, exercise habits, and ongoing medical support that can partially compensate for the loss of the drug’s effects.
The 14.9% average weight loss seen in trials represents what’s possible with consistent use over about 16 months. Some people lose more, some less. About a third of participants in the STEP 1 trial lost 20% or more of their body weight, while others saw more modest results in the 5 to 10% range. Setting expectations around the average, rather than the best-case outcomes often highlighted on social media, gives you a more accurate picture of what the medication can realistically do.